S alt sensitivity is defined as a quantitative trait in which an increase in sodium (Na + ) load leads to an increase in blood pressure (BP).
S alt sensitivity is defined as a quantitative trait in which an increase in sodium (Na + ) load leads to an increase in blood pressure (BP). 1, 2 Although universal consensus does not exist on the exact quantity of the Na + load, the magnitude of the pressure increase, or the specific protocol details required for this designation, the presence of salt sensitivity is clearly associated with an increased prevalence of cardiovascular events and mortality, irrespective of unchallenged BP levels. [3] [4] [5] Indeed, normotensive salt-sensitive (SS) individuals have a cumulative mortality rate similar to that of hypertensive (HT) patients. 4 In addition, SS individuals, even those with normal BP levels when initially studied, have a greater age-related increase in BP. 6 Overall, salt sensitivity has been estimated to be present in 51% of HT and 26% of normotensive subjects, posing a major public health problem in the United States and other Westernized societies. 7 The underlying pathophysiological mechanisms of salt sensitivity are currently unknown. 8 However, there is strong evidence that genetic mechanisms may underlie variations in the BP response to dietary salt intake. 2, [9] [10] [11] In particular, there is tight maternal-offspring association of BP change with dietary Na + restriction. 9 Salt sensitivity, hypertension, and related cardiovascular diseases are thought to result from the interaction of genes with the environment (eg, stress and diet), but the specific genes involved in susceptibility to salt sensitivity have not been completely clarified. 2 The Na + -bicarbonate co-transporter gene (SLC4A5) on chromosome 2 encodes a protein that transports Na + and HCO 3 − electrogenically across the basolateral membranes of many cell types, including renal tubule cells, into the interstitial fluid and ultimately into the circulation. 12, 13 Single nucleotide polymorphisms (SNPs) of SLC4A5 have been associated with baseline and 10-year follow-up BP in previous studies. [14] [15] [16] [17] In the present study, we tested the hypothesis that SNPs in several candidate genes, but especially SLC4A5, are associated with salt sensitivity in 2 white populations examined by independent investigators.
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Methods

Study Participants
The present analyses were restricted to subjects with genotype and BP data: 55 HT and 130 normotensive white subjects from the University of Virginia (UVA) discovery cohort and 211 white HT subjects for the replication cohort (HyperPATH).
Human Subjects Protocol (UVA Cohort)
The study protocol and informed consent documents were approved by the UVA Institutional Review Board for Health Sciences Research.
Tests for genetic association for BP traits were performed in 185 subjects of European ancestry who were between the ages of 18 and 70 years with a body mass index (BMI) of 18 to 30. The subjects were deemed healthy as determined by screening history, physical examination, standard 12-lead ECG and laboratory testing (complete blood count, fasting comprehensive metabolic panel, lipid panel, and urinalysis with microscopy). The subjects were classified either as normotensive (BP <140 mm Hg systolic BP and <90 diastolic BP [DBP] mm Hg) or HT (history of previous diagnosis of hypertension or DBP 90-114 mm Hg after a 3-week withdrawal from all anti-HT medications or average BP readings during the prestudy screening period ≥140/90 mm Hg). Subjects with a history of malignant or accelerated hypertension; secondary causes of hypertension; contraindication to discontinuing anti-HT medications; serum creatinine >1.5 mg/dL; urinary protein excretion >500 mg/d; continuing active urinary sediment; previous myocardial infarction, stroke, or transient ischemic episode; congestive heart failure or severe small vessel disease; or concurrent pregnancy were excluded. HT subjects with systolic BP >180 mm Hg or DBP >114 mm Hg after withdrawal from anti-HT medications also were excluded. The study entailed 2 screening visits (genetic and prestudy) and a 3-week washout period for HT subjects taking anti-HT medications with weekly visits for BP monitoring. After completion of screening procedures and washout period, the subjects were placed on an isocaloric constant diet containing 1 g of protein per kilogram of body weight per day and 60 mmol/d of potassium (K + ) for 2 consecutive weeks. Individual caloric intake was determined by the subject's height, weight, age, and activity level. All food was weighed, measured, prepared, and obtained from the Research Diet Kitchen of the General Clinical Research Center of the University of Virginia Health System. On study days 1 to 7, Na + intake was either 10 or 300 mmol/d, and on study days 8 to 14 Na + intake was the opposite; the order of low and high Na + intake was randomized. BP, heart rate, height, and body weight were measured at each of 7 visits during the 2-week study period. BP measurements for the last day of each diet (3 separate measurements of BP taken over 45 minutes in the right arm with the subject in the sitting position) were averaged to identify salt sensitivity. Salt sensitivity was defined as a mean arterial pressure (MAP) increase of ≥7 mm Hg with the subject on high as compared with low Na + intake. Na + metabolic balance was confirmed with 3 consecutive 24-hour urine collections for Na + on the last 3 days of each diet. Subjects failing to achieve metabolic balance after a maximum of 7 days of the constant low or high Na + diet were excluded. HT subjects were excluded for systolic BP >180 mm Hg or DBP >114 mm Hg or for persistent cardiovascular symptoms while on the diet. To assess whether the order of diets affected the diagnosis of salt sensitivity, we compared those receiving a high-salt diet on the first week with those receiving a lowsalt diet on the first week. There was no evidence that the order of the diets affected the results (P=0.365, Wilcoxon rank-sum test).
HyperPATH Cohort and Study Protocol
The HyperPATH Cohort consists of subjects with mild hypertension studied from 4 international centers (Brigham and Women's Hospital, University of Utah Medical Center, Vanderbilt University, and Hospital Broussais [Paris, France]). The HyperPATH inclusionexclusion criteria and the detailed phenotyping protocol have been described previously and are briefly detailed below. 18, 19 Although results from the HyperPATH have been reported previously, 19 ,20 the present analyses are original.
All subjects received a screening history and physical and laboratory examinations. Hypertension was defined as a seated DBP of ≥100 mm Hg off anti-HT medications, ≥90 mm Hg while taking ≥1 medication, or treatment with ≥2 medications. Subjects requiring ≥4 anti-HT medications were excluded. A diagnosis of diabetes mellitus (previously diagnosed, fasting glucose >126 mg/dL, or glucose >200 mg/dL at 180 minutes after 75-gm glucose load), overt renal insufficiency (serum creatinine >1.5 mg/dL), stroke, psychiatric illness, any form of secondary hypertension, obesity (BMI >30 kg/m 2 ), current tobacco, or illicit drug use were excluded. Subjects with abnormal laboratory values or electrocardiographic evidence of heart block, ischemia, or previous coronary events at screening were excluded. All subjects were between the ages of 18 to 65 years. Race was selfdefined by each subject.
To control the influence that medications may play on the renin-angiotensin-aldosterone system, all angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or mineralocorticoid receptor antagonists were discontinued 3 months before the start of the study, and β-adrenergic receptor blockers were discontinued 1 month before the start of the study. If necessary, subjects were placed on amlodipine or hydrochlorothiazide for BP control. All medications were discontinued 2 weeks before the start of the study.
All participants received 2 alcohol-and caffeine-free isocaloric diets for 5 to 7 days each on an outpatient basis, high sodium (200 mmol/d) and low sodium (10 mmol/d) with each diet also containing 100 mmol/d of potassium and 20 mmol/d of calcium. The order of the diets was random. Subjects were then admitted overnight to the in-patient research center after each diet. On the final day of each diet, a 24-hour urine collection was obtained. All studied participants had a urine sodium ≥150 mmol/24 hours on the high-sodium diet and ≤30 mmol/24 hours on the low-sodium diet. BP measurements were obtained using an automated device (DINAMAP; Critikon, Tampa, FL). Three consecutive readings separated by 5 minutes were obtained after each diet and measured while the subject was supine. Salt sensitivity was defined as an MAP increase of ≥7 mm Hg with the subjects on high as compared with low Na + intake.
Candidate Gene and SNP Selection and Genotyping
Candidate SNPs were selected on the basis of previous association with salt sensitivity or hypertension. For the rationale for candidate gene and SNP selection, please see the online-only Data Supplement. In the UVA cohort, each SNP was genotyped using a fluorescent allele-specific polymerase chain reaction (PCR)-based assay. 21 This method has also been referred to in the literature as PCR amplification of specific alleles. Reaction components were assembled on a 384-well array tape platform (http://www.douglasscientific.com) using nanoliter volumes (500-1000 nL). PCR was carried out in a water bath thermocycler using standard 3-stage parameters (denature, primer annealing, and primer extension). The specific parameters of each PCR varied depending on the nature of the primers and the SNP being genotyped. The 384-well array tape was scanned after PCR amplification, and the ratio of fluorescent signals was used to determine the genotype (homozygous for 1 allele or heterozygous).
In the HyperPATH cohort, 2 SNPs in the SLC4A5 gene were genotyped for replication purposes, rs7571842 and rs10177833. The SNPs were genotyped using a 7600-SNP Illumina iSelect platform (Illumina, San Diego, CA). These genotyped SNPs had a completion rate of >90% and were in Hardy-Weinberg equilibrium in HyperPATH. Repeat genotyping demonstrated concordance with the original genotype call.
Statistical Analysis
Statistical analyses related to the UVA cohort were performed using STATA (version 11). Genotypic association was assessed for hypertension status at baseline and salt sensitivity (defined as ≥7-mm Hg increase in MAP on a high-salt diet) using χ 2 or Fisher exact test, where appropriate. 22 For SNPs that showed suggestive evidence of association (P≤0.1), logistic regression analyses were performed without adjustments for covariates and then adjusted for BMI, age, and sex for the hypertension comparison and for BMI and age for by guest on April 4, 2017 http://hyper.ahajournals.org/ Downloaded from salt sensitivity analyses. All SNPs were tested for Hardy-Weinberg equilibrium in cases and controls separately. Results were not adjusted for multiple comparisons; instead, significant results were tested for replication to assess for false positives in the HyperPATH data.
Statistical analyses related to the HyperPATH cohort were performed using SAS 9.1 (SAS Institute). Hardy-Weinberg equilibrium was evaluated using a χ 2 test. Population characteristics are displayed as mean values with SDs. Non normally distributed variables are shown as median values with the interquartile range. Logistic regression analyses were performed for salt sensitivity analyses and adjusted for age, BMI, sibling relatedness, and study site. A dominant genetic model (major allele homozygotes versus heterozygotes plus minor allele homozygotes) was conducted for all analyses.
Meta-Analysis
Genetic meta-analysis was conducted using a weighted Z-score method and implemented in the freely available METAL software package (http//www.sph.umich.edu/csg/abecasis/metal/). This approach accounts for the direction of association relative to a chosen reference allele and the sample size of each cohort. First, P values from each study are converted to Z scores. A weighted sum of Z scores is calculated where each statistic is weighted by the square root of the sample size for each study. The resulting sum is divided by the square root of the total sample size to obtain an overall Z statistic.
20,23
Results
Characteristics of the Discovery (UVA) Study Subjects
General Characteristics
Tests for genetic association for BP traits were performed in 185 UVA subjects. Of the 185 UVA subjects, 55 were HT at the initiation of the study. The HT group was heavier, older, and had a larger proportion of men than the normotensive group (P≤0.004 for all comparisons; Table 1 ). There were 34 subjects in the SS group and 151 subjects in the salt-resistant (SR) group (Table 2 ). The SS subjects were older than the SR subjects. There was no significant difference in BMI between SS and SR subjects. As expected, the distribution of SS subjects differed between the HT and normotensive subjects (P=0.004; Table 3 ). Demographic and clinical descriptions of the HyperPATH data are presented in Table S1 in the online-only Data Supplement.
High Na + Intake After 7 days of high Na + intake, urinary Na + excretion was similar in the UVA SS and SR groups at 226.3±37.8 and 218.8±57.3 mmol/24 hour, respectively (P=0.52). With subjects on high Na + intake, systolic, diastolic, and MAPs were higher in the SS than in the SR group (all P<0.0001) and plasma renin activity was higher in SR than in SS (P<0.05). There were no differences in resting heart rate or urine creatinine excretion between the SS and SR groups for either population.
Low Na + Intake After 7 days of low Na + intake, urinary Na + excretion also was similar in the SS and SR groups at 18.6±6.2 and 17.4±7.4 mmol/24 hour, respectively (P=0.31). With subjects on low Na + intake, DBP was higher in the SR group (P=0.02), but there was no significant difference in systolic or MAP between the 2 groups. There were no differences in resting heart rate or total urine creatinine excretion between the SS and SR groups. However, on low Na + intake plasma renin activity was higher in the SR subjects (P=0.03). The mean change in BP from high-salt to low-salt diet did not differ from that of low salt to high-salt diet (P=0.365).
Effect of High and Low Na
+ Intake on BP, Plasma Renin Activity, and Plasma Aldosterone Concentrations For both SS and SR groups, urinary Na + excretion was >10-fold higher with subjects on high as opposed to low Na + intake (P<0.0001 for both groups). In the SS group, systolic, diastolic, and MAPs were higher during high as compared with low Na + intake (all P<0.0001). However, for the SR group BP was not influenced by Na + intake. Plasma renin activity and aldosterone concentrations were both higher with low-than high Na + intake (P<0.0001).
Genetic Association Studies
A total of 35 SNPs in 17 candidate genes were assayed in the UVA population, but of these 8 were monomorphic in 1 phenotypic class and near monomorphic in the other and therefore not presented (Table 4 and Tables S2 and S3 in the online-only Data Supplement for the rationales for the choice of candidate genes and SNPs). Association analyses with salt sensitivity demonstrated 4 variants that were marginally associated with salt sensitivity, the 2 SNPs in SLC4A5, 1 SNP in the dopamine D 2 receptor (rs6276), and 1 SNP in G proteincoupled receptor kinase-4 (GRK4, rs2960306) (P<0.1; Table  4 ). Association with hypertension at baseline revealed 2 SNPs with a P<0.10, rs4961 in ADD1 (P=0.027) and rs1801058 in GRK4 (P=0.018). We examined each of these SNPs for association using logistic regression to determine effect sizes and to assess whether adjusting for covariates affected the results. For salt sensitivity only the 2 SNPs in SLC4A5 (rs7571842 and rs10177833) demonstrated significant results using logistic regression. These 2 SNPs had P values of 1.04×10 −4 and 3.1×10 −4 and odds ratios (ORs) of 0.221 and 0.221, respectively (Table 5) . After adjusting for BMI and age, the associations remained (P=8.9×10 −5 and 2.55×10 −4 and ORs 0.210 and 0.286, respectively). These 2 SLC4A5 SNPs were in linkage disequilibrium in both SS and SR UVA subjects, but the strength of the linkage disequilibrium was greater in SR than in SS subjects (r 2 =0.93 and 0.61, respectively), further supporting the conclusion of an association of UVA indicates University of Virginia; BMI, body mass index; BP, blood pressure; MAP, mean arterial pressure. If continuous variables were normally distributed, a t test was used to compare the 2 groups. If not normally distributed, a Wilcoxon-rank-sum was used to compare the 2 groups. The non normal variables were age, MAP (low salt), systolic BP (low salt), and diastolic BP (high and low salt). Also, note that BP measurements were uniformly higher in the hypertensive vs normotensive group (all P<0.0001).
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SLC4A5 with SS. The dopamine D 2 receptor SNP was still close to significant after adjusting for covariates (P=0.052).
For the hypertension analysis, the associations between GRK4 rs1801058 and ADD1 rs4961 remained significant (P<0.05) after adjusting for covariates (Table 6 ).
Because ADD1 and GRK4 are within 40 kb of each other, we adjusted each SNP in the logistic regression analyses for the other SNPs in addition to sex, BMI, and age to assess independence of these 2 SNPs. After adjustment for rs4961, rs1801058 remained statistically significant (P=0.016; OR, 0.545; 95% CI, 0.330-0.891), but the ADD1 SNP rs4961 did not remain significant after adjusting for GRK4 genotypes (P=0.524; OR, 0.968; 95% CI, 0.877-1.07).
Replication of the Association of SLC4A5 SNPs and Salt Sensitivity of BP: HyperPATH Protocol
Replication Associations between the 2 SLC4A5 SNPs from the UVA cohort and salt sensitivity were also tested in the HyperPATH cohort (Table 5 ) and significant associations were found for rs7571842 (P=0.02). SNP rs1017783 manifested trends for salt sensitivity that did not reach statistical significance (Table  5 ; P=0.06). The effects were in the same direction as for the UVA analyses (ORs 0.32 and 0.36, respectively). UVA indicates University of Virginia; BMI, body mass index; MAP, mean arterial pressure; BP, blood pressure; SS, salt sensitive; SR, salt-resistant. If continuous variables were normally distributed, a t test was used to compare the 2 groups. If not normally distributed, a Wilcoxon rank-sum was used to compare the 2 groups. The non-normal variables were age, MAP (low salt), systolic BP (low salt), and diastolic BP (high and low salt). Also, note that BP measurements were uniformly higher in the hypertensive vs normotensive group (all P<0.0001).
*Comparison of distribution of sex in SS vs SR subjects. UVA indicates University of Virginia; BP, blood pressure; SS, salt sensitive; SR, salt-resistant; HT, hypertensive; NT, normotensive. If continuous variables were normally distributed, a t test was used to compare the 2 groups. If not normally distributed, a Wilcoxon rank-sum was used to compare the 2 groups. The non normal variables were age, mean arterial pressure (low salt), systolic BP (low salt), and diastolic BP (high and low salt). Also, note that BP measurements were uniformly higher in the hypertensive vs normotensive group (all P<0.0001). 
Meta-Analysis
A meta-analysis of the 2 cohorts was carried out for salt sensitivity. As expected, both SNPs demonstrated highly significant associations with increased salt sensitivity (Table 7) (rs7571842 [P=1.2×10 −5 ], rs1017783 [P=1.1×10 −4 ]).
Discussion
Despite numerous genome-wide association studies (GWAS), the specific genetic causes of hypertension and salt sensitivity of BP have remained elusive. Several genes identified from GWAS have been shown collectively only to influence 2% of BP variability. 24 It is likely that the lack of variance is because GWAS was not designed to account for epistatic or gene-environment interactions. Salt sensitivity is of particular interest because the prevalence is estimated to be as high as 73% in HT subjects and 36% in normotensive blacks. 10 In Koreans, the incidence of salt sensitivity is 28%. 26 Retrospective studies have demonstrated that normotensives with salt sensitivity *P values based on 2×3 χ 2 analyses unless otherwise noted. †Data are based on pooling rare homozygotes with heterozygotes because of there being too few homozygotes. have mortality estimates that are equivalent to those of HT subjects. 4 Thus, the identification of gene variants associated with salt sensitivity might provide predictive testing to identify subjects for further workup and treatment.
Various DNA polymorphisms have been associated with salt sensitivity of BP. In Koreans, 4 gene variants were strongly associated with salt sensitivity, cytosolic branched chain aminotransferase 1 (rs7961152, OR=4.9; P=0.007); ATPase, Ca ++ transporting, plasma membrane 1 (ATP2B1, rs2681472; OR=3.8; P=0.040); fibroblast growth factor 5 (rs16998073, OR=2.1; P=0.042); and LOC100132798 (rs2398162; OR=3.5; P=0.023). 26 In elderly Amish, the Ste29-related proline-alaninerich kinase protein contains 2 polymorphisms in the STK39 locus (rs3754777 and rs6749447) that are associated with salt sensitivity. 27 We demonstrated previously that SNPs in GRK4 are highly associated with SS hypertension in Japanese 28 and Italians, 29 which was recapitulated in transgenic mice expressing the human GRK4 variants. 2 Additional polymorphisms in α-adducin (ADD1), angiotensin-converting enzyme, angiotensinogen, cytochrome P450/11B polypeptide 2, G-protein β3 subunit, and neural precursor cell expressed developmentally downregulated 4-like protein (NEDD4L) have been linked to SS hypertension. 2, 30 Because it is of interest to determine whether candidate genes are associated with salt sensitivity, independently of hypertension, we examined polymorphisms in a white cohort, containing subjects who were both normotensive and HT that had been phenotyped for salt sensitivity using controlled diets. Of most of the variants studied those important were nonsynonymous coding variants or those already shown to have biological function. Our results demonstrate that SLC4A5 variants are strongly associated with salt sensitivity in whites.
SLC4A5 was originally cloned from human heart in 2000. 31 Chromosome 2, the location of SLC4A5, was linked to increased BP in blacks and whites. 14, 32, 33 Building on this evidence, SLC4A5 was identified as a candidate hypertension susceptibility gene using several combined positional candidate gene methods. 34 Selected SNPs at positions SLC4A5 (rs6731545), SLC4A5 A/C (rs1017783), and SLC4A5 A/G (rs7571842) were associated with elevated heart rate and BP in both whites and blacks. 15, 16, 30 Our results are consistent in that the allele associated with increased BP in Hunt et al 15 was also our risk allele (A) for salt sensitivity of BP.
The SLC4A5 gene codes for Na + -bicarbonate cotransporter-4, also termed NBCe2, an electrogenic Na + -bicarbonate cotransporter that helps maintain the homeostasis of intracellular pH by cotransporting 3 bicarbonate anions for each Na + cation independently of chloride. 35 Not much is known about the role of NBCe2 in renal physiology. NBCe2 is expressed in various organs including the kidney, heart, and brain. 36 Within the human kidney, NBCe2 mRNA is expressed in the thick ascending limb of Henle, and the protein has been localized in the luminal plasma membranes of the cortical collecting duct. 37, 38 A recent study demonstrated that SLC4A5 knockout mice are HT and have compensated metabolic acidosis. 39 It was reasoned that deletion of SLC4A5 initiates compensatory bicarbonate reabsorption via other Na + -bicarbonate transporters at the expense of increased tubule Na + uptake. 39 Investigators also have speculated that NBCe2 might be a promising candidate for the strong linkage signal found in response to renin-angiotensin system inhibiting drugs, highlighting its potential importance in SS hypertension .40 Increased Na + transport is involved in genetic hypertension. 41 Even if SLC4A5 plays a minor role in Na + balance, a decrease of only 0.1% in Na + excretion can in the long run lead to hypertension. For example, a human excretes 1% of filtered Na + (≈250 mmol/d). A decrease in Na + excretion of only 0.1% leads to Na + retention of 25 mmol/d or 250 mmols in 10 days, the cumulative effect of which can be substantial. Our results provide a new line of strong evidence that this gene is associated with salt sensitivity of BP.
The association of SLC4A5 with salt sensitivity has heretofore not been identified in GWAS. Effects of the sizes we detected would likely have been seen in GWAS, but this would only have been true if the same phenotype(s) were measured. For BP, per se, our effect sizes are small and likely would not have been observed in GWAS. Our results for salt sensitivity could not have been detected in GWAS because our data were based on a totally different approach emphasizing phenotype This study has some limitations. First, results for hypertension, per se, could have been affected by the fact that the HT subjects were not severely HT, possibly reducing our power to detect an effect. Second, the sample sizes of both populations are relatively small; however, both populations have similar meticulous phenotyping protocols that are unavailable in most large-scale BP cohorts. Furthermore, the meta-analysis adds power and validity to the salt sensitivity finding. The crosssectional nature of this analysis limits our ability to draw conclusions of causality, and additional studies are necessary to determine the functionality of this genetic variant with salt sensitivity. Strengths of the analysis include the following: (1) use of extensive phenotyping including dietary control of Na + , (2) use of a meta-analysis approach to validate previous findings, and (3) the fact that similar results were found in 2 independent studies.
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Perspectives
GWAS have identified genes that influence only 2% of BP variability and have not identified genes that influence the salt sensitivity of BP. Only a few genes have been found to be associated with SS hypertension using candidate gene association studies. The strong association of 2 SLC4A5 SNPs with salt sensitivity of BP may provide an impetus to study gene variants that are associated with salt sensitivity. These results may have bearing on the recommendation of low Na + diet in the prevention and treatment of cardiovascular disease. What Is New?
• Na + -bicarbonate cotransporter (SLC4A5) gene variants are strongly associated with salt sensitivity of blood pressure (BP) in 2 independent white populations.
What Is Relevant?
• Salt sensitivity is a quantitative trait in which an increase in Na + load induces an increase in BP.
• Salt sensitivity is associated with an increased prevalence of cardiovascular events and mortality independently of the BP level.
• Salt sensitivity is present in approximately one half of hypertensive and one quarter of normotensive individuals, thus posing a major public health problem.
• The genetic basis for salt sensitivity has not been fully elucidated.
• The present study demonstrates that single nucleotide polymorphisms of SLC4A5 are strongly associated with salt sensitivity independently of baseline BP.
• Identification of gene variants such as SLC4A5 with the pathogenesis of salt sensitivity may have important implications for dietary Na + restriction in subjects with these variants.
